Human amniotic membrane products for patients with diabetic foot ulcers. do they help? a systematic review and meta‐analysis
Open Access
- 14 September 2022
- journal article
- review article
- Published by Wiley in Journal of Foot and Ankle Research
- Vol. 15 (1) , 1-12
Abstract
Background: Diabetic foot ulcer (DFU) is one of the most serious diabetic complications. DFU is an open wound that usually occurs in the foot sole due to poor blood glucose control, peripheral neuropathy, and poor circulation. The human amniotic allograft membrane is a biological wound dressing derived from the amniotic membrane. It contains amino acids, nutrients, cytokines, and growth factors that make the growth process easier.Objective: To compare dehydrated human amnion and chorion allograft (DHACA) plus the standard of wound care (SOC) with the SOC alone.Methods: We searched for randomized clinical trials (RCTs) on PubMed, Scopus, Cochrane, and Web of Science till April 2021 using relevant keywords. All search results were screened for eligibility. We extracted the data from the included trials and pooled them as mean difference (MD) or risk ratio (RR) with the 95% confidence interval (CI) using Review Manager software (ver. 5.4).Results: The pooled effect estimate from 11 RCTs showed that DHACA was superior to SOC regarding the complete wound healing in both 6th and 12th week (RR = 3.78; 95% CI: [2.51, 5.70]; P < 0.00001) and (RR = 2.00; 95% CI: [1.67, 2.39], P < 0.00001 respectively). Also, the analysis favored the DHACA regarding the mean time to heal in the 12th‐week (MD = ‐12.07, 95%CI: [‐19.23, ‐4.91], P = 0.001). The wound size reduction was better with DHACA (MD = 1.18, 95%CI: [‐0,10, 2.26], P = 0.03).Conclusion: Using DHACA with SOC is safer and more effective than using SOC alone for DFU patients.Keywords
Funding Information
- Assiut University
This publication has 35 references indexed in Scilit:
- A clinical trial of Integra Template for diabetic foot ulcer treatmentWound Repair and Regeneration, 2015
- Diabetic foot ulcer—A review on pathophysiology, classification and microbial etiologyDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2015
- A prospective, randomised, controlled, multi‐centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcersInternational Wound Journal, 2014
- The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi‐centre, controlled, randomised, blinded, clinical trialInternational Wound Journal, 2014
- A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcersInternational Wound Journal, 2013
- Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound HealingInternational Journal of Vascular Medicine, 2012
- Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre studyInternational Wound Journal, 2009
- Reevaluating the Way We Classify the Diabetic FootDiabetes Care, 2008
- Risk Factors for Foot Infections in Individuals With DiabetesDiabetes Care, 2006
- Angiogenic and growth factors in human amnio‐chorion and placentaEuropean Journal of Clinical Investigation, 1983